Amylyx Pharmaceuticals, Inc. AMLX Q4 2025 Annual earnings
Reported March 3, 2026 · Before market open
Revenue-
EPS-$0.30Beat by $0.01
EPS estimate-$0.31
Next report
Aug 6, 2026 (In 1 week)EPS estimate-$0.36
Financials
Q4 2025Valuation & ratios
Versus estimates
Revenue
Diluted EPS
Ask the moment Amylyx Pharmaceuticals, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Amylyx Pharmaceuticals, Inc. report Q4 2025 earnings?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported Q4 2025 earnings on March 3, 2026 before market open.
- What were Amylyx Pharmaceuticals, Inc.'s Q4 2025 revenue and EPS?
- Amylyx Pharmaceuticals, Inc. reported revenue of - and eps of $-0.30 for Q4 2025.
- Did Amylyx Pharmaceuticals, Inc. beat estimates in Q4 2025?
- EPS beat the consensus estimate of $-0.31 by $0.01.
- How did Amylyx Pharmaceuticals, Inc.'s Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 100.0% from $665.0K a year earlier and eps grew 45.5% from $-0.55.
- Where can I find Amylyx Pharmaceuticals, Inc.'s Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001193125-26-086629) and the 10-K periodic report (0001193125-26-086645) directly on SEC EDGAR. The filing index links above go to sec.gov.